FDA Clears Pfizer Shot for Teens; U.S. Cases Slow: Virus Update
Bloomberg 1 day ago
(Bloomberg)
The U.S. Food and Drug Administration approved the use of Pfizer-BioNTech vaccine for children aged 12 to 15. The number of new cases in U.S. rose last week at the slowest pace since the pandemic began, as more Americans are vaccinated and the nation recovers from a winter spike fueled by holiday travel.
India’s capital of New Delhi extended its lockdown for another week as it battled a wave of infections and warned about a potentially deadly fungal infection in Covid-19 patients. Meanwhile, the World Health Organization sees the highly contagious variant spreading in India as a global concern.
Covid-19: Global Cases Fall but the Virus Is Surging in Countries That Lack Vaccines
Last Updated
May 12, 2021, 8:27 a.m. ETMay 12, 2021, 8:27 a.m. ET
The W.H.O. says a coronavirus variant first found in India is a “variant of concern.” The F.D.A. authorizes the Pfizer-BioNTech vaccine for 12- to 15-year-olds.
Follow our live
Here’s what you need to know:
Buddhist monks were tested at a temple in Bangkok after a monk there died of Covid-19.Credit.Rungroj Yongrit/EPA, via Shutterstock
After a devastating year with wave after wave of coronavirus infections around the world, new cases and deaths are falling in many of the Western nations that were once among the hardest hit. But while the virus recedes in wealthy nations with robust vaccination campaigns, it is pummeling India and threatening to swamp Southeast Asian countries that until now had largely kept the virus at bay.